EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors

Eloïse Ramel, Sorilla Prey, Caroline Dutriaux, Emilie Gerard, Anne Pham-Ledard, Marie Beylot-Barry, Marie Kostine

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2023.113477 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Eloïse Ramel und 6 weiteren Autor:innen. Beteiligte Einrichtung: ImmunoConcEpT, Univ. Bordeaux, F-33000 Bordeaux, France. Electronic address: eloise.ramel@gmail.com. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Melanoma, Protein Kinase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsMelanomaProtein Kinase InhibitorsMolecular Targeted TherapyHumansDrug InteractionsRetrospective StudiesProgression-Free SurvivalMaleFemaleAdultMiddle AgedAgedAged, 80 and overProto-Oncogene Proteins B-raf

Stichwörter der Autor:innen

BRAF inhibitor /MEK inhibitorCo-medicationsMelanomaProton pump inhibitorTargeted therapy

Substanzen

Proton Pump InhibitorsProtein Kinase InhibitorsBRAF protein, humanProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • ImmunoConcEpT, Univ. Bordeaux, F-33000 Bordeaux, France. Electronic address: eloise.ramel@gmail.com.
  • Department of Dermatology, CHU de Bordeaux, F-33000 Bordeaux, France; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France.
  • Department of Dermatology, CHU de Bordeaux, F-33000 Bordeaux, France.
  • ImmunoConcEpT, Univ. Bordeaux, F-33000 Bordeaux, France; Department of Rheumatology, Bordeaux University Hospital, Bordeaux, France.

Zitieren

APA

Ramel, E., Prey, S., Dutriaux, C., Gerard, E., Pham-Ledard, A., Beylot-Barry, M., & Kostine, M. (2024). Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113477

Vancouver

Ramel E, Prey S, Dutriaux C, Gerard E, Pham-Ledard A, Beylot-Barry M, et al. Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2023.113477

BibTeX
@article{Ramel2024,
  author = {Ramel, Eloïse and Prey, Sorilla and Dutriaux, Caroline and Gerard, Emilie and Pham-Ledard, Anne and Beylot-Barry, Marie and Kostine, Marie},
  title = {Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2023.113477}
}
Kostenlos starten →